Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy
Authors
Keywords
Pancreatic neuroendocrine tumor, Tumor heterogeneity, [<sup>68</sup>Ga], [<sup>177</sup>Lu]-DOTATATE/-DOTATOC, PET/CT, SSTR
Journal
MOLECULAR IMAGING AND BIOLOGY
Volume -, Issue -, Pages -
Publisher
Springer Nature
Online
2018-07-17
DOI
10.1007/s11307-018-1252-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues
- (2017) Rodney J. Hicks et al. NEUROENDOCRINOLOGY
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Peptide Receptor Radionuclide Therapy Outcomes in a North American Cohort With Metastatic Well-Differentiated Neuroendocrine Tumors
- (2017) Nancy Sharma et al. PANCREAS
- A phase II study of axitinib in advanced neuroendocrine tumors
- (2016) J R Strosberg et al. ENDOCRINE-RELATED CANCER
- Long-term follow-up and role of FDG PET in advanced pancreatic neuroendocrine patients treated with 177Lu-D OTATATE
- (2016) Maddalena Sansovini et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Intratumoral heterogeneity of 18F-FDG uptake predicts survival in patients with pancreatic ductal adenocarcinoma
- (2016) Seung Hyup Hyun et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- The asphericity of the metabolic tumour volume in NSCLC: correlation with histopathology and molecular markers
- (2016) Ivayla Apostolova et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Nephrotoxicity after PRRT with 177Lu-DOTA-octreotate
- (2016) Hendrik Bergsma et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Texture analysis of 18F-FDG PET/CT to predict tumour response and prognosis of patients with esophageal cancer treated by chemoradiotherapy
- (2016) Masatoyo Nakajo et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Semiquantitative Parameters in PSMA-Targeted PET Imaging with 18 F-DCFPyL: Variability in Normal-Organ Uptake
- (2016) Xin Li et al. JOURNAL OF NUCLEAR MEDICINE
- Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
- (2016) James C Yao et al. LANCET
- Predictive Value of Asphericity in Pretherapeutic [111In]DTPA-Octreotide SPECT/CT for Response to Peptide Receptor Radionuclide Therapy with [177Lu]DOTATATE
- (2016) Christoph Wetz et al. MOLECULAR IMAGING AND BIOLOGY
- Survival prediction in patients undergoing radionuclide therapy based on intratumoral somatostatin-receptor heterogeneity
- (2016) Rudolf A. Werner et al. Oncotarget
- A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management
- (2016) Kjell Oberg et al. Endocrine Connections
- Revisiting the Robustness of PET-Based Textural Features in the Context of Multi-Centric Trials
- (2016) Clément Bailly et al. PLoS One
- Imaging approaches to assess the therapeutic response of gastroenteropancreatic neuroendocrine tumors (GEP-NETs): current perspectives and future trends of an exciting field in development
- (2015) Rocio Garcia-Carbonero et al. CANCER AND METASTASIS REVIEWS
- Textural features in pre-treatment [F18]-FDG-PET/CT are correlated with risk of local recurrence and disease-specific survival in early stage NSCLC patients receiving primary stereotactic radiation therapy
- (2015) Thomas Pyka et al. Radiation Oncology
- Non–Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of18F-FDG Uptake at PET—Association with Treatment Response and Prognosis
- (2015) Gary J. R. Cook et al. RADIOLOGY
- False Discovery Rates in PET and CT Studies with Texture Features: A Systematic Review
- (2015) Anastasia Chalkidou et al. PLoS One
- Outcome of peptide receptor radionuclide therapy with 177Lu-octreotate in advanced grade 1/2 pancreatic neuroendocrine tumours
- (2014) Samer Ezziddin et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 18F-FDG PET Uptake Characterization Through Texture Analysis: Investigating the Complementary Nature of Heterogeneity and Functional Tumor Volume in a Multi-Cancer Site Patient Cohort
- (2014) M. Hatt et al. JOURNAL OF NUCLEAR MEDICINE
- Predictors of Long-Term Outcome in Patients with Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors After Peptide Receptor Radionuclide Therapy with 177Lu-Octreotate
- (2014) S. Ezziddin et al. JOURNAL OF NUCLEAR MEDICINE
- Textural Parameters of Tumor Heterogeneity in 18F-FDG PET/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer
- (2014) R. A. Bundschuh et al. JOURNAL OF NUCLEAR MEDICINE
- SUV of [68Ga]DOTATOC-PET/CT Predicts Response Probability of PRRT in Neuroendocrine Tumors
- (2014) C. Kratochwil et al. MOLECULAR IMAGING AND BIOLOGY
- Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
- (2014) Hugo J. W. L. Aerts et al. Nature Communications
- The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours
- (2013) John J. Zaknun et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Pancreatic Enucleation: Improved Outcomes Compared to Resection
- (2012) C. E. Cauley et al. JOURNAL OF GASTROINTESTINAL SURGERY
- The Epidemiology of Gastroenteropancreatic Neuroendocrine Tumors
- (2011) Ben Lawrence et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Baseline 18F-FDG PET image-derived parameters for therapy response prediction in oesophageal cancer
- (2011) Mathieu Hatt et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Intratumor Heterogeneity Characterized by Textural Features on Baseline 18F-FDG PET Images Predicts Response to Concomitant Radiochemotherapy in Esophageal Cancer
- (2011) F. Tixier et al. JOURNAL OF NUCLEAR MEDICINE
- Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
- (2011) Eric Raymond et al. NEW ENGLAND JOURNAL OF MEDICINE
- Impact of the Ki-67 proliferation index on response to peptide receptor radionuclide therapy
- (2010) Samer Ezziddin et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Distant metastasis occurs late during the genetic evolution of pancreatic cancer
- (2010) Shinichi Yachida et al. NATURE
- Evaluation of spatial resolution of a PET scanner through the simulation and experimental measurement of the recovery coefficient
- (2009) E. Prieto et al. COMPUTERS IN BIOLOGY AND MEDICINE
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
- (2009) Anja Rinke et al. JOURNAL OF CLINICAL ONCOLOGY
- 68Ga-DOTA-Tyr3-Octreotide PET for Assessing Response to Somatostatin-Receptor-Mediated Radionuclide Therapy
- (2009) M. Gabriel et al. JOURNAL OF NUCLEAR MEDICINE
- Methods and Limitations of Assessing New Noninvasive Tests
- (2008) Rory Hachamovitch et al. CIRCULATION
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
- Heterogeneity of tumor prognostic markers: a reproducibility study applied to liver metastases of pancreatic endocrine tumors
- (2008) Anne Couvelard et al. MODERN PATHOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now